Healthcare and cancer treatment costs of breast screening outcomes among higher than average risk women
Mittmann N, Blackmore KM, Seung SJ, Diong C, Done SJ, Chiarelli AM. Curr Oncol. 2023; 30(9):8550-8562.
Publications
The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: an interrupted time series analysis
Zeitouny S, Cheung DC, Bremner KE, Pataky RE, Pequeno P, Matelski J, Peacock S, Del Giudice ME, Lapointe-Shaw L, Tomlinson G, Mendlowitz AB, Mulder C, Tsui TCO, Perlis N, Walker JD, Sander B, Wong WWL, Krahn MD, Kulkarni GS. PLoS One. 2023; 18(9):e0290646. Epub 2023 Sep 8.
The association between household food insecurity and healthcare costs among Canadian children
Clemens KK, Le B, Anderson KK, Comeau J, Tarasuk V, Shariff SZ. Can J Public Health. 2023; Aug 23 [Epub ahead of print].
A province-by-province cost-effectiveness analysis and budget impact analysis of one-time birth cohort screening of hepatitis C virus (HCV) infection in Canada
Wong WWL, Haines A, Wong J, Hamadeh A, Krahn MD. Sci Rep. 2023; 13(1):13484. Epub 2023 Aug 18.
The impact of transition of Spina Bifida Care: a retrospective population-based cohort study comparing outcomes and healthcare costs longitudinally from adolescence into adulthood
Playfair M, McClure JA, Le B, Cassidy C, Wang P, Welk B, Dave S. Paediatr Child Health (Oxford). 2023; Jul 5 [Epub ahead of print].
Impact of neighborhood social deprivation on healthcare costs associated with TAVR
Sidhu H, Qiu F, Manoragavan R, Ko DT, Mamas MA, Sud M, Tam DY, Wijeysundera HC. Circ Cardiovasc Qual Outcomes. 2023; (7):e009761. Epub 2023 Jun 29.
Hospital encounters and associated costs of prostate evaluation for clinically important disease MRI vs. standard evaluation procedures (PRECISE) study from a provincial-payer perspective
Seung SJ, Saherawala H, Nguyen L, Gatley JM, Liu N, Kebabdjian M, Earle C, Klotz L, Mittmann N. Can Urol Assoc J. 2023; 17(8):280-4. Epub 2023 May 30.
Effect of free medicine distribution on healthcare costs in Canada over 3 years: a secondary analysis of the CLEAN Meds randomized clinical trial
Persaud N, Bedard M, Boozary A, Glazier RH, Gomes T, Hwang SW, Jüni P, Law MR, Mamdani M, Manns B, Martin D, Morgan SG, Oh P, Pinto AD, Shah BR, Sullivan F, Umali N, Thorpe KE, Tu K, Wu F, Laupacis A; CLEAN Meds study team. JAMA Health Forum. 2023; 4(5):e231127. Epub 2023 May 26.
Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis
Situ M, Schwarz UI, Zou G, McArthur E, Kim RB, Garg AX, Sarma S. Eur J Health Econ. 2023; May 17 [Epub ahead of print].
Primary care services and emergency department visits in blended fee-for-service and blended capitation models: evidence from Ontario, Canada
Hong M, Devlin RA, Zaric GS, Thind A, Sarma S. Eur J Health Econ. 2023; May 8 [Epub ahead of print].